Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dachuang Cao

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Genetics|February 3, 2005
A model selection-based interval-mapping method for autopolyploidsDachuang Cao, Bruce A Craig, R W Doerge
Genome Research|February 14, 2004
Correct estimation of preferential chromosome pairing in autotetraploidsDachuang Cao, Thomas C Osborn, Rebecca W Doerge
Diabetes, Obesity & Metabolism|May 14, 2025
Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trialTheresa Hunter Gibble, Dachuang Cao, Tammy Forrester, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 13, 2017
Initiation of Basal Insulin Analog Treatment for Type 2 Diabetes and Reasons Behind Patients' Treatment Persistence Behavior: Real-World Data from GermanyElisabeth Moennig, Magaly Perez-Nieves, Irene Hadjiyianni, et al.
Clinical Lung Cancer|August 3, 2012
A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment rationale and study designEdward B Garon, Dachuang Cao, Ekaterine Alexandris, et al.
Current Medical Research and Opinion|October 26, 2017
Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetesIgnacio Conget, M Sue Kirkman, Dachuang Cao, et al.
Obesity (Silver Spring, Md.)|September 3, 2025
Tirzepatide Associated With Improved Health-Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT-4Theresa Hunter Gibble, Dachuang Cao, Madhumita Murphy, et al.
Revista Da Associacao Medica Brasileira (1992)|November 14, 2019
Basal insulin persistence in Brazilian participants with T2DMDenise Reis Franco, Magaly Perez-Nieves, Jasmina I Ivanova, et al.
Current Medical Research and Opinion|June 13, 2017
Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational surveyMark Peyrot, Magaly Perez-Nieves, Jasmina Ivanova, et al.
Lancet (London, England)|July 9, 2010
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trialMichaela Diamant, Luc Van Gaal, Stephen Stranks, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Genetics|February 3, 2005
A model selection-based interval-mapping method for autopolyploidsDachuang Cao, Bruce A Craig, R W Doerge
Genome Research|February 14, 2004
Correct estimation of preferential chromosome pairing in autotetraploidsDachuang Cao, Thomas C Osborn, Rebecca W Doerge
Diabetes, Obesity & Metabolism|May 14, 2025
Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trialTheresa Hunter Gibble, Dachuang Cao, Tammy Forrester, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 13, 2017
Initiation of Basal Insulin Analog Treatment for Type 2 Diabetes and Reasons Behind Patients' Treatment Persistence Behavior: Real-World Data from GermanyElisabeth Moennig, Magaly Perez-Nieves, Irene Hadjiyianni, et al.
Clinical Lung Cancer|August 3, 2012
A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment rationale and study designEdward B Garon, Dachuang Cao, Ekaterine Alexandris, et al.
Current Medical Research and Opinion|October 26, 2017
Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetesIgnacio Conget, M Sue Kirkman, Dachuang Cao, et al.
Obesity (Silver Spring, Md.)|September 3, 2025
Tirzepatide Associated With Improved Health-Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT-4Theresa Hunter Gibble, Dachuang Cao, Madhumita Murphy, et al.
Revista Da Associacao Medica Brasileira (1992)|November 14, 2019
Basal insulin persistence in Brazilian participants with T2DMDenise Reis Franco, Magaly Perez-Nieves, Jasmina I Ivanova, et al.
Current Medical Research and Opinion|June 13, 2017
Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational surveyMark Peyrot, Magaly Perez-Nieves, Jasmina Ivanova, et al.
Lancet (London, England)|July 9, 2010
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trialMichaela Diamant, Luc Van Gaal, Stephen Stranks, et al.
Pageof 5